Filed under: Major Movement , Competitive Strategy , Barrick Gold (ABX) , Commodities , Federal Reserve Back in the late 1970s, the Hunt brothers from Texas tried to corner the silver market . That drove prices to $48 an ounce. Now, 31 years later, silver is shooting higher again. The March silver futures contract closed at $32.296 per ounce , up 72 cents. Since gold is expensive, investors are turning to silver to hedge against inflation. Many fear that the Federal Reserve will not be able to control the spike in commodity prices. The Fed is buying $600 billion of treasuries and keeping interest rates near zero. Continue reading Silver Near a 31-Year High Silver Near a 31-Year High originally appeared on BloggingStocks on Sat, 19 Feb 2011 12:50:00 EST. Please see our terms for use of feeds . Permalink | Email this | Comments
Tag: free republic
FedEx (FDX): Still Set to Deliver?
Filed under: Newsletters , FedEx Corp (FDX) , Stocks to Buy “It’s not too often that a company lowers its guidance and the stock rises, but such is the case with FedEx ( FDX ),” says Geoffrey Seiler . The editor of BullMarket .com explains, “The company cut its fiscal Q3 guidance; but given the terrible weather, which impacted a number of airports across the U.S. and Europe, and higher fuel costs, it was largely expected. “The package delivery firm now expects to produce adjusted EPS of 70-90 cents, down from prior guidance of 95 cents to $1.15. Analysts were expecting EPS of $1.04 for the quarter. Continue reading FedEx (FDX): Still Set to Deliver? FedEx (FDX): Still Set to Deliver? originally appeared on BloggingStocks on Wed, 16 Feb 2011 10:30:00 EST. Please see our terms for use of feeds . Permalink | Email this | Comments
Celgene (CELG): A Biotech Takeover Target?
Filed under: Newsletters , Stocks to Buy “As tradition holds, Celgene ( CELG ) gave the first presentation at the recent 29th JP Morgan Healthcare Conference, where CEO Bog Hugin focused on Celgene’s ongoing plans to become a world-wide company and expansion into global markets,” reports John McCamant . The biotech specialist and editor of The Medical Technology Stock Letter explains, “They expect 2011 to be the first year where the company earns a majority of sales outside the U.S. The company is currently conducting 25 Phase III trials on its various drugs. “Celgene also announced 4th quarter 2010 earnings last week, and revenue was down 16%, mostly based on costs incurred due to the Abraxis acquisition. Continue reading Celgene (CELG): A Biotech Takeover Target? Celgene (CELG): A Biotech Takeover Target? originally appeared on BloggingStocks on Tue, 15 Feb 2011 13:00:00 EST. Please see our terms for use of feeds . Permalink | Email this | Comments
Would Ben Graham Buy Apple (AAPL)?
Filed under: Apple Inc (AAPL) , Newsletters , Stocks to Buy “Is Apple (( AAPL ) undervalued? We expect the company’s earnings to grow at a rapid 24% pace during the next five years,” says J. Royden Ward who believe the tech stock meets the criteria for a long-term value investment. The editor of Cabot Benjamin Graham Value Letter explains, “At 14.7 times our one-year forward EPS estimate, shares are clearly undervalued. Indeed, we consider AAPL to be low risk. “Apple develops, manufactures and markets personal computers and consumer electronic products. Exciting new products portend continued rapid growth in future years. Continue reading Would Ben Graham Buy Apple (AAPL)? Would Ben Graham Buy Apple (AAPL)? originally appeared on BloggingStocks on Mon, 14 Feb 2011 10:20:00 EST. Please see our terms for use of feeds . Permalink | Email this | Comments
Oil Services Favorites: Schlumberger, National Oilwell Varco
Filed under: Newsletters , Schlumberger Limited (SLB) , Commodities , Oil , Stocks to Buy “Oil had a good year in 2010, rising 15 percent, and 2011 looks to be even better, as a stronger global economy pushes demand for resources higher,” says Stephen Leeb . The editor of The Complete Investor explains, “Oil service and equipment companies are the most leveraged way to play rising oil prices. Here’s a look a Schlumberger ( SLB ) and National Oilwell Varco ( NOV ). “First is Schlumberger, operating in more than 80 countries. The company is the world’s leading supplier of energy technology, project management, and information solutions. Continue reading Oil Services Favorites: Schlumberger, National Oilwell Varco Oil Services Favorites: Schlumberger, National Oilwell Varco originally appeared on BloggingStocks on Wed, 09 Feb 2011 12:40:00 EST. Please see our terms for use of feeds . Permalink | Email this | Comments
Four Plays on 3-D: IMAX, RLD, DLB, TDSC
Filed under: Newsletters , Stocks to Buy “In only a few years, 3-D will have a third of the TV market and a sizable chunk of the box office. I have no doubt that this will be one of the ‘Next Big Things’,” suggests Andy Obermueller . The editor of Game-Changing Stocks explains, “Here, I review the overall market as well as the four best stock plays in the sector. I see each of these stocks as having serious growth potential as 3-D technology takes off. “3-D functionality is becoming increasingly available on many high-end TVs. Last year was the first year that 3-D TVs were available; manufacturers sold 3.2 million 3-D sets vs. 247 million HDTVs. Continue reading Four Plays on 3-D: IMAX, RLD, DLB, TDSC Four Plays on 3-D: IMAX, RLD, DLB, TDSC originally appeared on BloggingStocks on Wed, 09 Feb 2011 10:30:00 EST. Please see our terms for use of feeds . Permalink | Email this | Comments
All That Jazz (JAZZ): Biotech Targets Narcolepsy, OCD and Anxiety
Filed under: Newsletters , Stocks to Buy “The visible growth story at Jazz Pharmaceuticals ( JAZZ ) is the narcolepsy treatment Xyrem, which accounts for 85% of revenues,” says growth stock specialist Mike Cintolo . The editor of Cabot Top Ten Weekly Report explains, “But Jazz has great potential to make big money with other drugs too-all of which focus on the chemistry of the brain. “Thanks to patents, Jazz has a decade to run with Xyrem before generic competitors can enter the market. Meanwhile, its drugs have potential to treat and/or cure obsessive-compulsive disorders, anxiety disorders, fibromyalgia, epilepsy and restless leg syndrome. Continue reading All That Jazz (JAZZ): Biotech Targets Narcolepsy, OCD and Anxiety All That Jazz (JAZZ): Biotech Targets Narcolepsy, OCD and Anxiety originally appeared on BloggingStocks on Tue, 08 Feb 2011 11:00:00 EST. Please see our terms for use of feeds . Permalink | Email this | Comments
Fidelity Expert Picks ‘Manager of the Year and the Decade’
Filed under: Newsletters , Mutual Funds , Stocks to Buy “Using my proprietary rankings system, I ran both a decade rankings and a 2010 rankings to derive in a purely quantitative manner my ‘Manager Of The Decade’ and ‘Manager Of The Year’,” says Jim Lowell . The editor of Fidelity Investor explains, “There’s nothing personal, nor subjective about my ranking system; it’s strictly quantitative (i.e., objective), by the numbers. “They simply reveal who can and can’t pick stocks, how consistently, and with what degree of risk vs. correlated benchmark and relevant peer group. Continue reading Fidelity Expert Picks ‘Manager of the Year and the Decade’ Fidelity Expert Picks ‘Manager of the Year and the Decade’ originally appeared on BloggingStocks on Fri, 04 Feb 2011 16:40:00 EST. Please see our terms for use of feeds . Permalink | Email this | Comments
MIPS Technologies (MIPS): Sell-Off Creates Opportunity
Filed under: Newsletters , Stocks to Buy “MIPS Technologies ( MIPS ) fell sharply after announcing its quarterly results; nevertheless, we think the long-term bullish thesis is intact,” says tech sector specialist Paul McWilliams . The editor of Next Inning explains, “It appears that Wall Street is focusing on slicing and dicing pennies rather than taking time to understand the story. Here’s our assessment. What we want from MIPS are license deals in its focus market (it signed three new licenses in the mobile sector last quarter), increasing unit royalties (it reported royalty on a record 173M units, up from 157M last quarter and 126M one year ago). Continue reading MIPS Technologies (MIPS): Sell-Off Creates Opportunity MIPS Technologies (MIPS): Sell-Off Creates Opportunity originally appeared on BloggingStocks on Fri, 28 Jan 2011 12:40:00 EST. Please see our terms for use of feeds . Permalink | Email this | Comments
ASML Holding NV (ASML): ‘Quiet Star’ in Mobile Devices
Filed under: Newsletters , Stocks to Buy “Don’t worry about whether the iphone will beat the Android, or the Galaxy the ipad; rather, you should buy the maker of chip machines for mobile devices,” says Frida Ghitis . The contributing editor to Global Investing explains, “Spun off from Phillips, ASML Holdings NV ( ASML ) — a quiet high tech star — is the world leader making lithography system machines for chipmaking by the semiconductor industry. Continue reading ASML Holding NV (ASML): ‘Quiet Star’ in Mobile Devices ASML Holding NV (ASML): ‘Quiet Star’ in Mobile Devices originally appeared on BloggingStocks on Thu, 27 Jan 2011 15:00:00 EST. Please see our terms for use of feeds . Permalink | Email this | Comments
TAL International (TAL): Shipping Income
Filed under: Newsletters , Commodities , Oil , Agriculture , Stocks to Buy “TAL International ( TAL ) is one of the worlds largest lessor of containers; its annual dividend of $1.60 provides a current yield of 5.3%,” says income specialist Amy Calistri . The editor of The Daily Paycheck explains, “In today’s global economy, roughly 90% of non-bulk cargo is transported by container ships. Interestingly enough, most shipping lines don’t own the actual containers; they lease them. “This wasn’t necessarily the type of stock you wanted to be in when the global economy ground to a halt. But as the world’s economies and trade improve, this is one company that benefits first. Continue reading TAL International (TAL): Shipping Income TAL International (TAL): Shipping Income originally appeared on BloggingStocks on Thu, 20 Jan 2011 13:00:00 EST. Please see our terms for use of feeds . Permalink | Email this | Comments
Natural Gas Service (NGS): Gas Field Gains
Filed under: Newsletters , Commodities , Oil , Stocks to Buy “I am getting more interested in natural gas; we all realize that crude oil production is peaking and that new discoveries are deep, dangerous to exploit, and bottom line expensive,” says resource expert Curtis Hesler . The editor of Professional Timing Service explains, “Investors can consider Natural Gas Service Group ( NGS ), a natural gas field equipment provider that I am adding to our recommended list. “While technology is improving in wind and hydroelectric generation, perhaps the greatest technical strides are being seen in natural gas production. Continue reading Natural Gas Service (NGS): Gas Field Gains Natural Gas Service (NGS): Gas Field Gains originally appeared on BloggingStocks on Wed, 19 Jan 2011 13:00:00 EST. Please see our terms for use of feeds . Permalink | Email this | Comments
